Common questions
Can you take MOTS-c with retatrutide?
Yes, but do not start both on the same day. Standard community protocols run retatrutide alone for the first 4 weeks at 1 mg weekly to confirm GI tolerance, then add MOTS-c at Week 5. The compounds use different mechanisms, so there are no known direct interactions, but both lower blood glucose, so monitor carefully if you also use metformin, berberine, or train fasted.
How much MOTS-c should I take with retatrutide?
Two common approaches. The intermittent approach uses 5–10 mg of MOTS-c, 2–3 times per week, usually on training days. The low-dose daily approach starts at 200 mcg per day and steps up to about 1 mg per day. Most community protocols use the intermittent approach because MOTS-c stays active in the AMPK pathway for roughly 72 hours per injection.
What is the recommended dose when taking MOTS-c with retatrutide?
Retatrutide is titrated from 1 mg up by 4-week steps (1 → 2 → 4 → 6 → 9 mg), with 12 mg as the maximum tested dose. MOTS-c is added at Week 5 at 5 mg, 2–3 times per week.
Is there a pre-blended retatrutide + MOTS-c vial?
No. As of June 2026, no commercial supplier offers retatrutide and MOTS-c in a single pre-blended vial. The two compounds have very different reconstituted-stability windows—MOTS-c is only stable for about 7 days at 2–8 °C, while retatrutide stays stable for 28–60 days—which makes a pre-blend impractical. Use separate vials.
How do you reconstitute the retatrutide + MOTS-c stack?
Reconstitute each compound separately with bacteriostatic water. A 10 mg retatrutide vial with 1 mL BAC water gives 10 mg/mL (a 4 mg dose = 40 units on a U-100 syringe). A 10 mg MOTS-c vial with 1 mL BAC water gives 10 mg/mL (a 5 mg dose = 50 units). Inject the BAC water slowly down the inside of the glass, roll gently, never shake. Refrigerate both vials right after reconstitution.
Open the reconstitution calculator →Does MOTS-c help with muscle loss on retatrutide?
This is the main reason researchers pair them. Preclinical evidence links MOTS-c to reduced myostatin signaling. MOTS-c also activates AMPK in muscle and improves mitochondrial function, which supports training capacity when calories are low. No human trial has confirmed this for retatrutide protocols specifically—the case is mechanistic plus community observation.
Is the retatrutide + MOTS-c stack safe?
Each compound has been studied on its own, but the combination has not been tested in any trial. Retatrutide's TRIUMPH-4 trial reported nausea in 38.1–43.2% of participants, dysesthesia in 8.8–20.9% (dose-dependent), and discontinuation rates of 12.2–18.2%. MOTS-c safety data is limited to animal studies and the CB4211 analog Phase 1 trial. The main combined concerns are amplified hypoglycemia risk, GI tolerance, and the standard contamination risk of using two grey-market compounds.
How long should I run the retatrutide + MOTS-c stack?
Retatrutide is run open-ended in clinical trials—TRIUMPH-4 lasted 68 weeks. MOTS-c is usually cycled: 4–8 weeks on, 2–4 weeks off, repeated through the retatrutide cycle. Most community protocols run the combined stack for 16–24 weeks before evaluating results and either continuing, tapering, or moving to maintenance.